Nihon Kohden Middle East

Nihon Kohden Middle East Nihon Kohden Middle East (NKME) is a subsidiary of Nihon Kohden Corporation, Japan. Nihon Kohden is

“We contribute to the world by challenging conquest of illness and a health increase with advanced technology”
“Develop a product which can compete in the world market”

Did you know that every minute, four women are diagnosed with breast cancer worldwide? 🌍 Breast cancer is the most commo...
02/10/2025

Did you know that every minute, four women are diagnosed with breast cancer worldwide?

🌍 Breast cancer is the most common cancer among women globally, but early detection and regular screening can significantly increase survival rates. This Breast Cancer Awareness Month, let’s raise awareness, encourage proactive health checks, and support every woman affected by this disease.

25/09/2025

We’re excited to introduce the Nihon Kohden Risk Prediction System powered by CoMET® – an advanced AI-driven solution designed to transform patient care by predicting critical events before they happen.

What makes it unique?
🟠 Event & Population-Specific Indices: Sepsis, Respiratory, Hypotension, Hemorrhage, Mortality, ICU Transfer
🟠 Advanced Warning: Up to 12 hours before clinical signs of deterioration
🟠 Comprehensive Data Use: Continuous cardiorespiratory monitoring + EMR data (vital signs & labs)
🟠 Intuitive Access: Viewable from any browser or device
🟠 Actionable Insights: Empowering clinicians to make timely, life-saving decisions

By harnessing AI, we can shift from reactive to proactive healthcare—supporting both better clinical outcomes and smarter use of hospital resources.

23/09/2025

Blood cancer diagnosis often begins with a simple CBC checkup, a critical first step that can reveal early signs of abnormal blood cell counts. 🩸

At Nihon Kohden, our Celltac hematology analyzers integrate advanced technology and unique functions to support clinicians in making accurate and timely diagnostic decisions. 🔬

In this video, MEK is back to explain how Celltac plays a key role in the hematological diagnosis process, from initial detection to guiding further clinical investigations.

⁉️ What are your tips for identifying early blood abnormalities? Comment below.

Thank you Jordanian Royal Medical Services الخدمات الطبية الملكية for your support and the trust you put in us with ARC ...
17/09/2025

Thank you Jordanian Royal Medical Services الخدمات الطبية الملكية for your support and the trust you put in us with ARC system. It was an honor to have this unique software from Ordinatrum in your esteem hospital as a trial phase and we are looking forward for more cooperation with JRMS. Thank you again for your hospitality.

Real-Life Case from Tunis 🩸| Blood Cancer Awareness Month🎗️This 75-year-old patient has been closely monitored since 201...
17/09/2025

Real-Life Case from Tunis 🩸| Blood Cancer Awareness Month🎗️
This 75-year-old patient has been closely monitored since 2015, with findings showing the progression and treatment response of chronic leukemia.

Using the Celltac G+ analyzer, abnormal blood parameters were detected early, enabling physicians to make timely and informed treatment decisions, ultimately supporting better patient outcomes.

Case shared by Dr. Mehziya Boussen, Biologist-Pharmacist, Dr. Gaied Mehziya Laboratory, Tunisia.

Meet the NK Protective Control®️ Redefining safety, efficiency, and confidence in critical care.Paired with the NKV 550 ...
10/09/2025

Meet the NK Protective Control®️
Redefining safety, efficiency, and confidence in critical care.

Paired with the NKV 550 Series Ventilator and Life Scope G Series bedside monitor, it lets clinicians manage care from outside the room—keeping patients safe and staff protected.

💡 Why it matters:
✔ Enhanced patient safety – Respond instantly to changing conditions
✔ Protects healthcare providers – Remote control reduces PPE use & exposure
✔ Stronger infection control – Limit room entry for immunocompromised patients

Empowering clinicians with the tools to deliver safe, effective care—every time.

🔹 Learn more: https://ae.nihonkohden.com/en

Case from | Blood Cancer Awareness Month🎗️A was presented with (ALL), and further investigation with our ana...
08/09/2025

Case from | Blood Cancer Awareness Month🎗️

A was presented with (ALL), and further investigation with our analyzer revealed abnormal . Alongside film findings, these results supported the and guided the next steps in .

Such real-world cases remind us of the importance of and solutions in improving patient .

🩸Check the case feedback below from Dr. Naila Saleem Saleh.

بمناسبة المولد النبوي الشريف، نتقدم إليكم بأطيب التهاني والتبريكات، سائلين الله أن يعيده عليكم بالخير واليمن والبركات 🤍✨...
05/09/2025

بمناسبة المولد النبوي الشريف، نتقدم إليكم بأطيب التهاني والتبريكات، سائلين الله أن يعيده عليكم بالخير واليمن والبركات 🤍✨

- - -

On this blessed occasion of the birth of Prophet Mohammed (PBUH), we extend our heartfelt wishes of peace, prosperity, and blessings to you and your families 🤍.

Did you know that leukaemia can develop either rapidly or slowly❓Understanding its classification is essential for deter...
04/09/2025

Did you know that leukaemia can develop either rapidly or slowly❓

Understanding its classification is essential for determining the right treatment approach. Broadly, leukaemia is divided into two main types based on how quickly it progresses: acute and chronic.🩸

At Nihon Kohden, we believe early and accurate blood analysis is vital. Our Celltac solutions support physicians in detecting abnormal blood cell patterns, helping guide timely treatment decisions.

👉 Learn more about the four main types of leukaemia: ALL, AML, CLL, and CML.

03/09/2025

Transforming Healthcare with Nihon Kohden Digital Health Solution NKDHS

At NKDHS, we are committed to shaping the future of patient care by connecting innovation with clinical excellence. Our solutions empower hospitals to:
🟦 Improve patient safety and outcomes
🟦 Enable predictive, data-driven care
🟦 Drive efficiency through digital transformation

With our Digital Health Platform, we integrate live and historical patient data into one secure system—giving healthcare teams real-time insights that lead to better decisions and improved outcomes.

Alongside this, we are developing innovative applications like CoMET and Netkonnect to enhance clinical diagnosis and enable remote monitoring, bringing healthcare closer to patients than ever before.

🔗 Together with our partners, we are building a smarter, connected, and sustainable future for healthcare.

Globally, approximately 1.24 million new cases of blood cancers, including leukaemia, lymphoma, and myeloma, are diagnos...
01/09/2025

Globally, approximately 1.24 million new cases of blood cancers, including leukaemia, lymphoma, and myeloma, are diagnosed each year.🌍

Early detection is essential, and that’s why this September, our Blood Cancer Awareness Month journey will highlight different aspects of this disease, starting with:
- Definition of blood cancer
- Its different types
- Normal blood cells compared to cells in the case of leukaemia under the microscope

➡️ Swipe right to learn more and stay tuned as we share real-life cases and insightful information about blood cancer.

28/08/2025

September is around the corner, and so is Blood Cancer Awareness Month 🩸.

We’re preparing something impactful to raise , share , and highlight the importance of .

Stay tuned and keep an eye on our upcoming posts 🎗️!

Address

Jafza One Tower A, 19th Floor, Office No 1912
Dubai
261516

Opening Hours

Monday 08:00 - 16:00
Tuesday 08:00 - 16:00
Wednesday 08:00 - 16:00
Thursday 08:00 - 16:00
Friday 08:00 - 16:00

Telephone

+97148840080

Website

Alerts

Be the first to know and let us send you an email when Nihon Kohden Middle East posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category